Metabolic control of satellite cell activation and muscle regeneration by the Glutamate-Pyruvate Transaminase GPT2
Skeletal Muscle (SkM) regeneration depends on Satellite Cells (SCs) activation and differentiation, processes that are tightly regulated by cellular metabolism. Despite growing evidence linking metabolic enzymes to stem cell fate, the role of aminotransferases in SCs function remains largely unexplored. In this study, we investigated the contribution of the Glutamate-Pyruvate Transaminase 2 (GPT2) to SC biology and muscle regeneration. We first analyzed GPT2 expression in quiescent versus activated SCs and found that GPT2 is preferentially expressed in the quiescent cell compartment. Flow cytometry analysis of sorted SCs revealed distinct GPT2-associated cellular profiles, supporting a link between GPT2 expression and SC stemness. To determine the in vivo relevance of GPT2, we assessed muscle regeneration following cardiotoxin-induced injury in a murine GPT2 +/− model. GPT2 haploinsufficiency resulted in delayed muscle repair compared with Wild-Type (WT) mice, indicating that GPT2 is required for an efficient regenerative response. Metabolic profiling revealed that, compared to WT, GPT2 +/− muscles displayed higher levels of α-ketoglutarate (α-KG), together with alterations in Alanine, Glutamine, and Pyruvate, identifying GPT2 as a key regulator of muscle metabolic homeostasis. Finally, we observed a marked reduction of GPT2 expression in the dystrophic D2. mdx mouse model, suggesting that defective GPT2-dependent metabolic regulation may contribute to impaired regeneration in muscular dystrophy. Compared to WT, D2. mdx muscles showed lower α-KG levels. Notably, α-KG administration improved the neuromotor control, exercise performance and the expression of myogenic markers in dystrophic mice. Overall, our findings identify GPT2 as a metabolic regulator of SC activation and differentiation and highlight α-KG homeostasis as a potential therapeutic target to enhance muscle regeneration in dystrophic conditions.
Authors
- Melania Murolo (ORCID: https://orcid.org/0000-0001-7930-9905)
- Monica Dentice (ORCID: https://orcid.org/0000-0002-9977-3761)
- Paolo Luciano
- Caterina Miro (ORCID: https://orcid.org/0000-0002-1008-8443)
- Mariano Stornaiuolo (ORCID: https://orcid.org/0000-0003-2200-5083)
- Annarita Nappi (ORCID: https://orcid.org/0000-0002-0876-3323)
- Giuseppe Pignataro (ORCID: https://orcid.org/0000-0002-7290-4397)
- Serenella Anzilotti (ORCID: https://orcid.org/0000-0002-8729-0009)
- Serena Sagliocchi (ORCID: https://orcid.org/0000-0003-0796-1392)
- Annunziata Gaetana Cicatiello (ORCID: https://orcid.org/0000-0002-6008-7086)
- Emery Di Cicco (ORCID: https://orcid.org/0000-0001-8507-1809)
- Lucia Acampora (ORCID: https://orcid.org/0009-0001-8220-4212)
- Federica Restolfer (ORCID: https://orcid.org/0009-0001-3417-1575)
- Nunzia De Iesu
- Lorenzo D’Aniello
Institutions
- Institut Pasteur (FR)
- San Raffaele University of Rome (IT)
- CEINGE Biotecnologie Avanzate Franco Salvatore (Italy) (IT)
- University of Naples Federico II (IT)
Publication Details
- Journal
- Skeletal Muscle
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1186/s13395-026-00464-z
- Primary Topic
- Muscle Physiology and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00